LEADER 01640nam  2200433   450 
001 9910707284803321
005 20160601085924.0
035   $a(CKB)5470000002462657
035   $a(OCoLC)950968704
035   $a(OCoLC)995470000002462657
035   $a(EXLCZ)995470000002462657
100   $a20160601d2015      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aRecommendation followup memorandum report $eimplementing OIG recommendation could have reduced payments for DME infusion drugs by hundreds of millions of dollars
210  1$a[Washington, D.C.] :$cDepartment of Health and Human Services, Office of Inspector General,$d2015.
215   $as1 online resource (9 pages) $ccolor illustration
300   $aTitle from title screen (viewed May 31, 2016).
300   $a"Apr[il] 21 2015."
300   $a"OEI-12-15-00110."
320   $aIncludes bibliographical references.
517   $aRecommendation followup memorandum report 
606   $aMedicare$xFinance
606   $aInfusion therapy$zUnited States$xEquipment and supplies$xCosts
606   $aDrugs$xFinance$xGovernment policy$zUnited States
606   $aWaste in government spending$zUnited States
615  0$aMedicare$xFinance.
615  0$aInfusion therapy$xEquipment and supplies$xCosts.
615  0$aDrugs$xFinance$xGovernment policy
615  0$aWaste in government spending
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910707284803321
996   $aRecommendation followup memorandum report$93439988
997   $aUNINA